NASDAQ · APYX

Apyx Medical Corporation

$3.89 -$0.03 (-0.77%) 1D Market open
Session Pulse After hours 1 mentions on Fri No new SEC filings since Tue close its sector ranked 5/11 this week Full pulse →

Key Metrics

$165.07M
Market cap
P/E · TTM
$55.90M
Revenue · TTM
−$9.17M
Net income
EPS · TTM $-0.23
Dividend yield
Free cash flow −$8.99M
Beta · 1Y 1.48
EBITDA · TTM −$7.99M
Gross margin 63.2%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    A material event was filed (Form 8-K).

    8-K - Apyx Medical Corp (0000719135) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 7
    The stock moved +21.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 7
  • May 5
    From its Feb 2 high, the share price fell 37%.

    Peak close $4.40 on Feb 2; trough close $2.79 on May 5. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -37%
  • Mar 23
    The stock moved +14.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 23

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$165.07M
Enterprise value$169.02M
Shares outstanding42.1M
52-wk range$1.59 – $5.08
Avg volume · 20D162.4K
Net cash −$3.95M
Book value / share$0.32
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNASDAQ
About Apyx Medical Corporation
IPO dateApr 6, 1994
Employees205

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S2.95
P/FCF
EV/EBITDA
EV/Sales3.02
Graham №

Profitability

Gross 63.2%
Operating -15.6%
Net -16.4%
FCF -16.1%
ROE / ROIC -67.8% · -54.1%

Financial Health

Current ratio5.80
Quick ratio4.79
Debt / equity2.73
Debt / EBITDA -4.39
Net cash −$3.95M
Working capital$45.35M

Cash Flow · TTM

Operating CF −$7.87M
Capex −$1.12M
Free cash flow −$8.99M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

1.3
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings